We are live on ! Find out more
LPCN icon

Lipocine
LPCN

45 hedge funds and large institutions have $109M invested in Lipocine in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

78% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 9

51% more capital invested

Capital invested by funds: $72.4M → $109M (+$36.9M)

27% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 11

18% more funds holding

Funds holding: 38 → 45 (+7)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
45
Holders Change
+7
Holders Change %
+18.42%
% of All Funds
1.26%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
14
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
RA
Royce & Associates
New York
+$10.2M
2
GGHC
Gilder Gagnon Howe & Co
New York
+$7.11M
3
EI
EAM Investors
California
+$4.68M
4
BIT
BlackRock Institutional Trust
California
+$3.18M
5
TC
TFS Capital
Pennsylvania
+$2.35M

Top Sellers

1
AC
Armistice Capital
New York
-$7.29M
2
SM
Sabby Management
Florida
-$7.13M
3
LOAMU
Lombard Odier Asset Management (USA)
New York
-$3M
4
VAM
Visium Asset Management
New York
-$2.15M
5
Bank of America
Bank of America
North Carolina
-$713K
Name Holding Trade Value Shares
Change 		Change in
Stake
EDRH
51
Edmond de Rothschild Holding
Switzerland
– -$270K -1,851 Closed
EDRS
52
Edmond de Rothschild (Suisse)
Switzerland
– -$270K -1,851 Closed
EEG
53
E.E. Geduld
– -$172K -1,176 Closed
LCS
54
Levin Capital Strategies
New York
– -$89K -608 Closed
1 2
3

LPCN Hedge Fund Activity: Q3 2015 in Review

45 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q3 2015, worth a combined $109M — up 51% from $72.4M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new LPCN positions and 9 closed out — a net gain of 7 holders — while 14 added to existing stakes and 11 trimmed.

The largest buyer was Royce & Associates, adding an estimated $10.2M. The largest seller was Armistice Capital, exiting entirely with an estimated $7.29M sold.

  • 45 institutional investors held Lipocine (LPCN) as of Q3 2015, up from 38 in Q2 2015.
  • Funds reported $109M of Lipocine stock for Q3 2015, up 51% quarter-over-quarter.
  • 16 funds opened new Lipocine positions in Q3 2015 and 9 closed out, a net change of +7 holders.
  • The largest Lipocine buyer in Q3 2015 was Royce & Associates, an estimated $10.2M added.
  • The largest Lipocine seller in Q3 2015 was Armistice Capital, an estimated $7.29M sold.

Based on aggregated 13F filings for Q3 2015.